Ознакомительная версия. Доступно 8 страниц из 36
class="sup">5. Vasant D. et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021; 70(7):1214–1240.
6. Drossman D. et al. Rome Foundation clinical diagnostic criteria for disorders of gutbrain interaction. Gastroenterology 2022; 162(3):675–679.
7. Cash B. et al. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002; 97(11):2812–2819.
8. Gralnek I. et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000; 119(3):654–660.
9. Клинические рекомендации Министерства здравоохранения Российской Федерации «Синдром раздраженного кишечника», 2021 год. Доступны на сайте https://cr.minzdrav.gov.ru/
10. National Institute for Health and Care Excellence (NICE). Irritable bowel syndrome in adults. 3rd ed. London: National Institute for Health and Care Excellence (NICE); 2017.
11. Bayer S. et al. Habitual green kiwifruit consumption is associated with a reduction in upper gastrointestinal symptoms: a systematic scoping review. Adv Nutr 2022; 13(3):846–856.
12. Chey W. et al. AGA clinical practice update on the role of diet in irritable bowel syndrome: expert review. Gastroenterology 2022; 162(6):1737–1745.
К главе 7
1. Singh P. et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2018; 16(6):823–836.
2. Tortora R. et al. Coeliac disease in the elderly in a tertiary centre. Scand J Gastroenterol 2016; 51:1179–1183.
3. Cappello M. et al. Elderly onset celiac disease: a narrative review. Clin Med Insights Gastroenterol 2016;9:41–49.
4. Bai J. World Gastroenterology Organisation global guidelines: celiac disease. J Clin Gastroenterol 2017; 51(9):755–768.
5. Туе-Din J. et al. Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspective. Intern Med J 2015; 45(4):441–450.
6. Cohen I. et al. Gluten in celiac disease-more or less? Rambam Maimonides Med J 2019; 10(l):e0007.
7. Akobeng A. et al. Systematic review: tolerable amount of gluten for people with coeliac disease. Aliment Pharmacol Then 2008; 27(ll):1044–1052.
8. Food and Drug Administration Health hazard assessment for gluten exposure in Individuals with celiac disease: determination of tolerable daily intake levels and levels of concern for gluten. Электронная ссылка http://bit.ly/2QCT6TH.
9. Thompson T. et al. Gluten contamination of grains, seeds, and flours in the United States: a pilot study. J Am Diet Assoc 2010; 110(6):937–940.
10. Koerner T. etal. Gluten contamination in the Canadian commercial oat supply. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2011; 28(6):705–710.
11. Dale H. et al. Assessment of markers of gut integrity and inflammation in non-celiac gluten sensitivity after a gluten free-diet. Int J Gen Med 2021; 14:9459–9470.
12. Ajamian M. et al. Effect of gluten ingestion and F0DMAP restriction on intestinal epithelial integrity in patients with irritable bowel syndrome and self-reported non-coeliac gluten sensitivity. Mol Nutr Food Res 2021; 65(5):el901275.
13. Monteiro M. et al. Autism spectrum disorder: a systematic review about nutritional interventions. Rev Paul Pediatr 2020; 38:e2018262.
14. Lionetti E. et al. Re-challenge studies in non-celiac gluten sensitivity: a systematic review and meta-analysis. Front Physiol 2017; 8:621.
15. Potter M. et al. Incidence and prevalence of self-reported non-coeliac wheat sensitivity and gluten avoidance in Australia. Med J Aust 2020; 212(3): 126–131.
16. Diez-Sampedro A. et aL A gluten-free diet, not an appropriate choice without a medical diagnosis. J Nutr Metab 2019; 2019:2438934.
К главе 8
1. De Vos W. et al. Gut microbiome and health: mechanistic insights. Gut 2022; 71(5): 1020–1032.
2. Jandhyala S. et al. Role of the normal gut microbiota. World J Gastroenterol 2015; 21(29):8787–803.
3. Leviatan S. et al. An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species. Nat Commun 2022; 13(1):3863.
4. Ивашкин B. T. и соавт. Практические рекомендации Научного сообщества по содействию клиническому изучению микробиома человека (НС0ИМ) и Российской гастроэнтерологической ассоциации (РГА) по диагностике и лечению синдрома избыточного бактериального роста у взрослых. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2022; 32(3):68–85.
5. Pimentel М. et al. ACG clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol 2020;115(2):165–178.
К главе 9
1. Dale H. et al. Assessment of markers of gut integrity and inflammation in non-celiac gluten sensitivity after a gluten free-diet. Int J Gen Med 2021; 14:9459–9470.
2. Ajamian M. et al. Effect of gluten ingestion and FODMAP restriction on intestinal epithelial integrity in patients with irritable bowel syndrome and self-reported non-coeliac gluten sensitivity. Mol Nutr Food Res 2021; 65(5):el901275.
3. Shafiee N. et al. Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know? Intest Res 2021; 19(2):171–185.
4. Bischoff S. et al. ESPEN guideline on Clinical Nutrition in inflammatory bowel disease. Clin Nutr 2023; 42(3):352–379.
5. Gill P. et al. The role of diet and gut microbiota in regulating gastrointestinal and inflammatory disease. Front Immunol 2022; 13:866059.
6. Keewan E. et al. Are fried foods unhealthy? The dietary peroxidized fatty acid, 13-HPODE, induces intestinal inflammation in vitro and in vivo. Antioxidants (Basel) 2020; 9(10):926.
7. Epitome of current medical literature. Br Med J 1936; 2:E97.
8. Kwon S. et al. Clinical significance of erosive or ulcerative lesions isolated in terminal ileum. Intest Res 2012; 10(4):350–356.
9. Goulart R. et al. Facing terminal ileitis: going beyond Crohn's disease. Gastroenterology Res 2016; 9(l):l-9.
К главе 10
1. Chandra R. Cholecystokinin. Cure Opin Endocrinol Diabetes Obes 2007; 14(l):63–67.
2. Nasreen S. et al. Ultrasound imaging of gallbladder variants. Journal of the Anatomical Society of India, 2016; 65(2):118–122.
3. Бакулин И. Г. и соавт. Билиарный сладж: патогенез, этиология и лекарственная терапия // Терапевтический архив. — 2021. -Т. 93. — № 2. — С. 179–186.
4. Holzbach R. et al. Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. J Clin Invest 1973; 52:1467–1479.
5. Lee S. et al. Origin and fate of biliary sludge. Gastroenterology 1988; 94(1): 170–176.
6. Ko et al. Incidence, natural history, and risk factors for biliary sludge and stones during
Ознакомительная версия. Доступно 8 страниц из 36
